Cytogenetics of bone tumors

Ji-Yun Lee, Andrea R. Sternenberger, Shibo Li

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The presence or absence of specific cytogenetic rearrangements has been routinely used to classify hematological neoplastic disorders, as well as to provide management guidance, and to predict the outcome of these hematological disorders. Compared to hematological neoplastic disorders, the cytogenetic data of bone tumors is limited. This is due in part to the fact that bone tumors are extremely rare; they represent only 0.2% of all human malignancies, and it is more challenging to perform a chromosome analysis of a bone tumor. Also, it is extremely difficult, sometimes impossible, to analyze intratumoral karyotypic heterogeneity in bone tumors. Here, we intend to provide the current status of the cytogenetic aspects of bone tumors.

Original languageEnglish
Title of host publicationBone Cancer
Subtitle of host publicationPrimary Bone Cancers and Bone Metastases: Second Edition
PublisherElsevier Inc.
Pages293-303
Number of pages11
ISBN (Electronic)9780124167285
ISBN (Print)9780124167216
DOIs
Publication statusPublished - 2014 Aug 27

Fingerprint

Cytogenetics
Bone and Bones
Neoplasms
Chromosomes

Keywords

  • Bone cancer
  • Bone tumor
  • Cytogenetics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Lee, J-Y., Sternenberger, A. R., & Li, S. (2014). Cytogenetics of bone tumors. In Bone Cancer: Primary Bone Cancers and Bone Metastases: Second Edition (pp. 293-303). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-416721-6.00026-1

Cytogenetics of bone tumors. / Lee, Ji-Yun; Sternenberger, Andrea R.; Li, Shibo.

Bone Cancer: Primary Bone Cancers and Bone Metastases: Second Edition. Elsevier Inc., 2014. p. 293-303.

Research output: Chapter in Book/Report/Conference proceedingChapter

Lee, J-Y, Sternenberger, AR & Li, S 2014, Cytogenetics of bone tumors. in Bone Cancer: Primary Bone Cancers and Bone Metastases: Second Edition. Elsevier Inc., pp. 293-303. https://doi.org/10.1016/B978-0-12-416721-6.00026-1
Lee J-Y, Sternenberger AR, Li S. Cytogenetics of bone tumors. In Bone Cancer: Primary Bone Cancers and Bone Metastases: Second Edition. Elsevier Inc. 2014. p. 293-303 https://doi.org/10.1016/B978-0-12-416721-6.00026-1
Lee, Ji-Yun ; Sternenberger, Andrea R. ; Li, Shibo. / Cytogenetics of bone tumors. Bone Cancer: Primary Bone Cancers and Bone Metastases: Second Edition. Elsevier Inc., 2014. pp. 293-303
@inbook{a45002cf2c2149e88a2c655675a2990c,
title = "Cytogenetics of bone tumors",
abstract = "The presence or absence of specific cytogenetic rearrangements has been routinely used to classify hematological neoplastic disorders, as well as to provide management guidance, and to predict the outcome of these hematological disorders. Compared to hematological neoplastic disorders, the cytogenetic data of bone tumors is limited. This is due in part to the fact that bone tumors are extremely rare; they represent only 0.2{\%} of all human malignancies, and it is more challenging to perform a chromosome analysis of a bone tumor. Also, it is extremely difficult, sometimes impossible, to analyze intratumoral karyotypic heterogeneity in bone tumors. Here, we intend to provide the current status of the cytogenetic aspects of bone tumors.",
keywords = "Bone cancer, Bone tumor, Cytogenetics",
author = "Ji-Yun Lee and Sternenberger, {Andrea R.} and Shibo Li",
year = "2014",
month = "8",
day = "27",
doi = "10.1016/B978-0-12-416721-6.00026-1",
language = "English",
isbn = "9780124167216",
pages = "293--303",
booktitle = "Bone Cancer",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Cytogenetics of bone tumors

AU - Lee, Ji-Yun

AU - Sternenberger, Andrea R.

AU - Li, Shibo

PY - 2014/8/27

Y1 - 2014/8/27

N2 - The presence or absence of specific cytogenetic rearrangements has been routinely used to classify hematological neoplastic disorders, as well as to provide management guidance, and to predict the outcome of these hematological disorders. Compared to hematological neoplastic disorders, the cytogenetic data of bone tumors is limited. This is due in part to the fact that bone tumors are extremely rare; they represent only 0.2% of all human malignancies, and it is more challenging to perform a chromosome analysis of a bone tumor. Also, it is extremely difficult, sometimes impossible, to analyze intratumoral karyotypic heterogeneity in bone tumors. Here, we intend to provide the current status of the cytogenetic aspects of bone tumors.

AB - The presence or absence of specific cytogenetic rearrangements has been routinely used to classify hematological neoplastic disorders, as well as to provide management guidance, and to predict the outcome of these hematological disorders. Compared to hematological neoplastic disorders, the cytogenetic data of bone tumors is limited. This is due in part to the fact that bone tumors are extremely rare; they represent only 0.2% of all human malignancies, and it is more challenging to perform a chromosome analysis of a bone tumor. Also, it is extremely difficult, sometimes impossible, to analyze intratumoral karyotypic heterogeneity in bone tumors. Here, we intend to provide the current status of the cytogenetic aspects of bone tumors.

KW - Bone cancer

KW - Bone tumor

KW - Cytogenetics

UR - http://www.scopus.com/inward/record.url?scp=84942802042&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942802042&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-416721-6.00026-1

DO - 10.1016/B978-0-12-416721-6.00026-1

M3 - Chapter

AN - SCOPUS:84942802042

SN - 9780124167216

SP - 293

EP - 303

BT - Bone Cancer

PB - Elsevier Inc.

ER -